WHITE PINE CAPITAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
WHITE PINE CAPITAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$203,794
+1.6%
5,6250.0%0.08%
+1.3%
Q4 2022$200,644
-4.9%
5,625
-36.6%
0.08%
-12.4%
Q2 2020$211,000
+11.1%
8,875
-15.9%
0.09%
-7.3%
Q1 2020$190,000
-24.0%
10,5500.0%0.10%
-2.0%
Q4 2019$250,000
-48.1%
10,550
-39.9%
0.10%
-45.6%
Q3 2019$482,000
-30.3%
17,550
-16.1%
0.18%
-30.2%
Q2 2019$692,000
-8.3%
20,910
-2.9%
0.26%
-7.2%
Q1 2019$755,000
-20.2%
21,535
-24.4%
0.28%
-28.5%
Q4 2018$946,000
-26.1%
28,485
+12.0%
0.39%
-13.9%
Q3 2018$1,280,000
-15.9%
25,4250.0%0.45%
-16.8%
Q2 2018$1,522,000
+28.4%
25,425
-1.7%
0.54%
+24.5%
Q1 2018$1,185,000
+12.1%
25,875
-2.5%
0.44%
+13.0%
Q4 2017$1,057,000
-6.2%
26,525
-5.8%
0.39%
+12766.7%
Q3 2017$1,127,000
-9.5%
28,165
-2.5%
0.00%
-99.4%
Q2 2017$1,245,000
+36.7%
28,875
-0.8%
0.49%
+32.7%
Q1 2017$911,000
+24.6%
29,100
+0.5%
0.37%
+19.4%
Q4 2016$731,000
+6.6%
28,950
+4.3%
0.31%
+6.2%
Q3 2016$686,000
-21.9%
27,750
-35.6%
0.29%
-21.1%
Q2 2016$878,000
+103.7%
43,100
+52.4%
0.37%
+101.1%
Q1 2016$431,00028,2750.18%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders